Copyright Reports & Markets. All rights reserved.

Global Arginase 1 Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Arginase 1 Monoclonal Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Recombinant
    • 1.3.3 Non-recombinant
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Arginase 1 Monoclonal Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Flow Cytometry
    • 1.4.3 ELISA
    • 1.4.4 Western Blot
    • 1.4.5 Immunoprecipitation
    • 1.4.6 Immunofluorescence
    • 1.4.7 Other
  • 1.5 Global Arginase 1 Monoclonal Antibody Market Size & Forecast
    • 1.5.1 Global Arginase 1 Monoclonal Antibody Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Arginase 1 Monoclonal Antibody Sales Quantity (2021-2032)
    • 1.5.3 Global Arginase 1 Monoclonal Antibody Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sino Biological, Inc.
    • 2.1.1 Sino Biological, Inc. Details
    • 2.1.2 Sino Biological, Inc. Major Business
    • 2.1.3 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Product and Services
    • 2.1.4 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sino Biological, Inc. Recent Developments/Updates
  • 2.2 ZodelBiotec Ltd.
    • 2.2.1 ZodelBiotec Ltd. Details
    • 2.2.2 ZodelBiotec Ltd. Major Business
    • 2.2.3 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Product and Services
    • 2.2.4 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ZodelBiotec Ltd. Recent Developments/Updates
  • 2.3 Innovative Research
    • 2.3.1 Innovative Research Details
    • 2.3.2 Innovative Research Major Business
    • 2.3.3 Innovative Research Arginase 1 Monoclonal Antibody Product and Services
    • 2.3.4 Innovative Research Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Innovative Research Recent Developments/Updates
  • 2.4 Geno Technology, Inc.
    • 2.4.1 Geno Technology, Inc. Details
    • 2.4.2 Geno Technology, Inc. Major Business
    • 2.4.3 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Product and Services
    • 2.4.4 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Geno Technology, Inc. Recent Developments/Updates
  • 2.5 CLOUD-CLONE CORP.
    • 2.5.1 CLOUD-CLONE CORP. Details
    • 2.5.2 CLOUD-CLONE CORP. Major Business
    • 2.5.3 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Product and Services
    • 2.5.4 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CLOUD-CLONE CORP. Recent Developments/Updates
  • 2.6 Biomatik
    • 2.6.1 Biomatik Details
    • 2.6.2 Biomatik Major Business
    • 2.6.3 Biomatik Arginase 1 Monoclonal Antibody Product and Services
    • 2.6.4 Biomatik Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Biomatik Recent Developments/Updates
  • 2.7 Assay Genie
    • 2.7.1 Assay Genie Details
    • 2.7.2 Assay Genie Major Business
    • 2.7.3 Assay Genie Arginase 1 Monoclonal Antibody Product and Services
    • 2.7.4 Assay Genie Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Assay Genie Recent Developments/Updates
  • 2.8 Creative Diagnostics
    • 2.8.1 Creative Diagnostics Details
    • 2.8.2 Creative Diagnostics Major Business
    • 2.8.3 Creative Diagnostics Arginase 1 Monoclonal Antibody Product and Services
    • 2.8.4 Creative Diagnostics Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Creative Diagnostics Recent Developments/Updates
  • 2.9 MyBiosource, Inc.
    • 2.9.1 MyBiosource, Inc. Details
    • 2.9.2 MyBiosource, Inc. Major Business
    • 2.9.3 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Product and Services
    • 2.9.4 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MyBiosource, Inc. Recent Developments/Updates
  • 2.10 CUSABIO
    • 2.10.1 CUSABIO Details
    • 2.10.2 CUSABIO Major Business
    • 2.10.3 CUSABIO Arginase 1 Monoclonal Antibody Product and Services
    • 2.10.4 CUSABIO Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 CUSABIO Recent Developments/Updates
  • 2.11 Abbexa
    • 2.11.1 Abbexa Details
    • 2.11.2 Abbexa Major Business
    • 2.11.3 Abbexa Arginase 1 Monoclonal Antibody Product and Services
    • 2.11.4 Abbexa Arginase 1 Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Abbexa Recent Developments/Updates

3 Competitive Environment: Arginase 1 Monoclonal Antibody by Manufacturer

  • 3.1 Global Arginase 1 Monoclonal Antibody Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Arginase 1 Monoclonal Antibody Revenue by Manufacturer (2021-2026)
  • 3.3 Global Arginase 1 Monoclonal Antibody Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Arginase 1 Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Arginase 1 Monoclonal Antibody Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Arginase 1 Monoclonal Antibody Manufacturer Market Share in 2025
  • 3.5 Arginase 1 Monoclonal Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 Arginase 1 Monoclonal Antibody Market: Region Footprint
    • 3.5.2 Arginase 1 Monoclonal Antibody Market: Company Product Type Footprint
    • 3.5.3 Arginase 1 Monoclonal Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Arginase 1 Monoclonal Antibody Market Size by Region
    • 4.1.1 Global Arginase 1 Monoclonal Antibody Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Arginase 1 Monoclonal Antibody Consumption Value by Region (2021-2032)
    • 4.1.3 Global Arginase 1 Monoclonal Antibody Average Price by Region (2021-2032)
  • 4.2 North America Arginase 1 Monoclonal Antibody Consumption Value (2021-2032)
  • 4.3 Europe Arginase 1 Monoclonal Antibody Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Arginase 1 Monoclonal Antibody Consumption Value (2021-2032)
  • 4.5 South America Arginase 1 Monoclonal Antibody Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Arginase 1 Monoclonal Antibody Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 5.2 Global Arginase 1 Monoclonal Antibody Consumption Value by Type (2021-2032)
  • 5.3 Global Arginase 1 Monoclonal Antibody Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 6.2 Global Arginase 1 Monoclonal Antibody Consumption Value by Application (2021-2032)
  • 6.3 Global Arginase 1 Monoclonal Antibody Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 7.2 North America Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 7.3 North America Arginase 1 Monoclonal Antibody Market Size by Country
    • 7.3.1 North America Arginase 1 Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Arginase 1 Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 8.2 Europe Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 8.3 Europe Arginase 1 Monoclonal Antibody Market Size by Country
    • 8.3.1 Europe Arginase 1 Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Arginase 1 Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Arginase 1 Monoclonal Antibody Market Size by Region
    • 9.3.1 Asia-Pacific Arginase 1 Monoclonal Antibody Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Arginase 1 Monoclonal Antibody Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 10.2 South America Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 10.3 South America Arginase 1 Monoclonal Antibody Market Size by Country
    • 10.3.1 South America Arginase 1 Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Arginase 1 Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Arginase 1 Monoclonal Antibody Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Arginase 1 Monoclonal Antibody Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Arginase 1 Monoclonal Antibody Market Size by Country
    • 11.3.1 Middle East & Africa Arginase 1 Monoclonal Antibody Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Arginase 1 Monoclonal Antibody Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Arginase 1 Monoclonal Antibody Market Drivers
  • 12.2 Arginase 1 Monoclonal Antibody Market Restraints
  • 12.3 Arginase 1 Monoclonal Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Arginase 1 Monoclonal Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Arginase 1 Monoclonal Antibody
  • 13.3 Arginase 1 Monoclonal Antibody Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Arginase 1 Monoclonal Antibody Typical Distributors
  • 14.3 Arginase 1 Monoclonal Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Arginase 1 Monoclonal Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Arginase 1 Monoclonal Antibody is an unconjugated antibody to Arginase 1.
    This report is a detailed and comprehensive analysis for global Arginase 1 Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Arginase 1 Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Arginase 1 Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Arginase 1 Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Arginase 1 Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Arginase 1 Monoclonal Antibody
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Arginase 1 Monoclonal Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., ZodelBiotec Ltd., Innovative Research, Geno Technology, Inc., CLOUD-CLONE CORP., Biomatik, Assay Genie, Creative Diagnostics, MyBiosource, Inc., CUSABIO, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Arginase 1 Monoclonal Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Recombinant
    Non-recombinant
    Market segment by Application
    Flow Cytometry
    ELISA
    Western Blot
    Immunoprecipitation
    Immunofluorescence
    Other
    Major players covered
    Sino Biological, Inc.
    ZodelBiotec Ltd.
    Innovative Research
    Geno Technology, Inc.
    CLOUD-CLONE CORP.
    Biomatik
    Assay Genie
    Creative Diagnostics
    MyBiosource, Inc.
    CUSABIO
    Abbexa
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Arginase 1 Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Arginase 1 Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Arginase 1 Monoclonal Antibody from 2021 to 2026.
    Chapter 3, the Arginase 1 Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Arginase 1 Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Arginase 1 Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Arginase 1 Monoclonal Antibody.
    Chapter 14 and 15, to describe Arginase 1 Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.

    Buy now